Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,246,000 | 6,465,000 | 5,111,000 | 3,048,000 | 6,986,000 |
| Depreciation Amortization | 5,757,000 | 4,208,000 | 2,812,000 | 1,425,000 | 5,157,000 |
| Income taxes - deferred | -700,000 | -1,335,000 | -10,000 | -204,000 | -20,000 |
| Accounts receivable | -134,000 | N/A | N/A | N/A | 21,000 |
| Other Working Capital | 98,000 | -1,582,000 | -3,182,000 | -2,125,000 | 741,000 |
| Other Operating Activity | 3,925,000 | 2,395,000 | 683,000 | -336,000 | 1,803,000 |
| Operating Cash Flow | $16,192,000 | $10,151,000 | $5,414,000 | $1,808,000 | $14,688,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,239,000 | 12,000,000 | 5,764,000 | 4,926,000 | 17,251,000 |
| PPE Investments | -1,823,000 | -1,134,000 | -702,000 | -301,000 | -1,397,000 |
| Net Acquisitions | -18,368,000 | -17,679,000 | -4,616,000 | -110,000 | -16,466,000 |
| Purchase Of Investment | -8,011,000 | -4,771,000 | -3,126,000 | -1,308,000 | -9,542,000 |
| Sale Of Investment | 11,268,000 | 6,915,000 | 2,427,000 | 1,142,000 | 6,929,000 |
| Purchase Sale Intangibles | -176,000 | -96,000 | -96,000 | N/A | -99,000 |
| Other Investing Activity | -96,000 | -35,000 | -70,000 | 6,000 | 245,000 |
| Investing Cash Flow | $-7,791,000 | $-4,704,000 | $-323,000 | $4,355,000 | $-2,980,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,412,000 | 5,434,000 | 4,489,000 | 2,406,000 | 8,274,000 |
| Debt Issued | 10,976,000 | 5,031,000 | 5,031,000 | N/A | N/A |
| Debt Repayment | -7,689,000 | -4,317,000 | -4,317,000 | -1,536,000 | -2,990,000 |
| Common Stock Issued | 1,019,000 | 946,000 | 696,000 | 296,000 | 1,263,000 |
| Common Stock Repurchased | -5,000,000 | -5,000,000 | -5,000,000 | -5,000,000 | -6,160,000 |
| Dividend Paid | -7,317,000 | -5,496,000 | -3,675,000 | -1,854,000 | -6,940,000 |
| Other Financing Activity | -5,629,000 | -3,513,000 | -2,477,000 | -1,483,000 | -3,856,000 |
| Financing Cash Flow | $-9,228,000 | $-6,915,000 | $-5,253,000 | $-7,171,000 | $-10,409,000 |
| Exchange Rate Effect | -215,000 | -79,000 | -68,000 | -73,000 | -1,000,000 |
| Beginning Cash Position | 3,707,000 | 3,641,000 | 3,641,000 | 3,641,000 | 3,343,000 |
| End Cash Position | 2,666,000 | 2,094,000 | 3,411,000 | 2,561,000 | 3,641,000 |
| Net Cash Flow | $-1,041,000 | $-1,547,000 | $-230,000 | $-1,080,000 | $298,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,192,000 | 10,151,000 | 5,414,000 | 1,808,000 | 14,688,000 |
| Capital Expenditure | -1,823,000 | -1,134,000 | -702,000 | -301,000 | -1,397,000 |
| Free Cash Flow | 14,369,000 | 9,017,000 | 4,712,000 | 1,507,000 | 13,291,000 |